Keyword: Boehringer Ingelheim
Markets & Companies
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
News
13.09.2019
- German drugmaker Boehringer Ingelheim has announced a management reshuffle to take place on Jan. 1, 2020. The company has appointed Carine Brouillon, who currently oversees its...
Plant Construction & Process Technology
10.09.2019
- The quality specifications of biopharmaceuticals are enormous and require a long list of time-consuming analytics. A big disadvantage of these analytics so far was, that their...
News
18.07.2019
- Germany’s Boehringer Ingelheim has purchased AMAL Therapeutics for an undisclosed sum. AMAL is a private Swiss biotech that is focused on cancer immunotherapy and vaccines derived...
News
17.06.2019
- German drugmaker Boehringer Ingelheim and Danish biotech Gubra have announced a second collaboration and license agreement to develop novel poly-agonist peptides to treat obesity...
News
28.05.2019
- German drugmaker Boehringer Ingelheim is planning to invest around 1.6 billion pesos (about $84 million) at its three manufacturing sites in Mexico over the next two years, with...
News
10.05.2019
- The US market watchdog Public Citizen has sued the Food and Drug Administration (FDA), demanding that a district court in Washington, DC, require the agency to add “black box”...
News
06.12.2018
- Japan’s AGC, formerly Asahi Glass Co., has agreed to buy Malgrat Pharma Chemicals (MPC), a Spanish subsidiary of Boehringer Ingelheim that manufactures synthetic pharmaceutical...
